AirNexis Therapeutics: Series ADevelops therapeutics for pulmonary diseases, specifically COPDOct 4, 2026RoundOSAirNexis TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeries A